Shenzhen Trivalent Inactivated Influenza Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Shenzhen Trivalent Inactivated Influenza Vaccine, covering 2022-04-25 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age [Phase 3]